ALYSSA LARSON

Alyssa Larson serves as an Associate at RA Capital, a prominent multi-stage investment firm renowned for its evidence-based approach to investing in public and private healthcare and life sciences companies. In her pivotal role, Alyssa contributes significantly to the firm's rigorous investment process, helping to identify and assess groundbreaking opportunities within the dynamic biotechnology and pharmaceutical landscapes.

RA Capital is dedicated to fostering innovation that addresses critical unmet medical needs. As an Associate, Alyssa Larson is deeply involved in the comprehensive due diligence required to evaluate potential investments. This includes extensive market research, scientific and clinical data analysis, competitive landscape assessment, and financial modeling. Her work is crucial in supporting RA Capital's investment decisions across a broad spectrum of therapeutic areas and technological platforms.

Alyssa's investment focus aligns with RA Capital's broad mandate, encompassing novel therapeutics, diagnostics, medical devices, and innovative biotechnology platforms. She helps to scrutinize companies developing solutions in areas such as oncology, immunology, rare diseases, neuroscience, and infectious diseases. Her analytical capabilities are instrumental in discerning the scientific merit and commercial viability of emerging technologies and therapies that have the potential to transform patient care.

While specific details of her career background are not publicly disclosed, individuals in Alyssa Larson's role at a leading firm like RA Capital typically possess a robust foundation in science, finance, or a combination thereof. This often includes rigorous academic training in relevant scientific disciplines, coupled with experience in the biotechnology or pharmaceutical industry, venture capital, or strategic consulting. Such a background equips her with the critical thinking skills necessary to navigate complex scientific data and evaluate market opportunities effectively.

Through her contributions at RA Capital, Alyssa Larson plays an important part in advancing healthcare innovation. Her dedication to identifying promising companies helps to channel capital towards the development of new treatments and technologies, ultimately benefiting patients worldwide and driving progress within the life sciences ecosystem.